Director, See remarks · Ginkgo Bioworks Holdings, Inc. · Class A Common Stock
Side
M
Value
—
Shares
55.7K
Price
—
Executed
Oct 16, 2026
Disclosed
Oct 21, 2026
Disclosure timeline5 days from execution to publication · legal deadline 2 business days
Oct 16 executedOct 21, 2026 disclosed
DNA · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Option exercise — administrative, little informational value
Relative size+13 / 25
No reported dollar value · 59.7% of prior position
Filing timing+6 / 15
Disclosed 3 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Kelly Jason R filed this Form 4 reporting a option exercise of DNA on Oct 16, 2026. It became public on Oct 21, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, See remarks
Kelly Jason Rcik:0001845677
Issuer
Ginkgo Bioworks Holdings, Inc.cik:0001830214
Revision history · 0
No field has changed since this record was first ingested.
